Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael N Pollak

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
Novartis Foundation Symposium|November 26, 2004
Insulin-like growth factors and neoplasiaMichael N Pollak
Nature Reviews. Clinical Oncology|April 20, 2017
Cancer, obesity, and diabetes: TKIs exert multiple effects on glucose homeostasisMichael N Pollak
Cancer Discovery|August 29, 2012
Investigating metformin for cancer prevention and treatment: the end of the beginningMichael N Pollak
Cancer Prevention Research (Philadelphia, Pa.)|December 29, 2018
Cancer Prevention: A Message from the New Editors-in-ChiefRaymond N DuBois, Michael N Pollak
Nature Reviews. Cancer|April 3, 2003
Challenges to cancer control by screeningMichael N Pollak, William D Foulkes
Cancer Prevention Research (Philadelphia, Pa.)|November 1, 2022
Introducing Cancer Center Director Perspectives on PreventionRaymond N DuBois, Michael N Pollak
Cancer Prevention Research (Philadelphia, Pa.)|April 1, 2026
Appetite, Obesity, Metabolism, and Malignancy: Do Incretin-Mimetic Drugs Reduce Cancer Risk?Andrew G Renehan, Michael N Pollak
The Journal of Urology|December 3, 2014
The use of aspirin and the risk of mortality in patients with prostate cancerJonathan Assayag, Michael N Pollak, Laurent Azoulay
NPJ Precision Oncology|October 3, 2024
Targeting IGF-IR improves neoadjuvant chemotherapy efficacy in breast cancers with low IGFBP7 expressionChristopher Godina, Michael N Pollak, Helena Jernström
European Journal of Cancer (Oxford, England : 1990)|September 11, 2014
Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancerJonathan Assayag, Michael N Pollak, Laurent Azoulay
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
Novartis Foundation Symposium|November 26, 2004
Insulin-like growth factors and neoplasiaMichael N Pollak
Nature Reviews. Clinical Oncology|April 20, 2017
Cancer, obesity, and diabetes: TKIs exert multiple effects on glucose homeostasisMichael N Pollak
Cancer Discovery|August 29, 2012
Investigating metformin for cancer prevention and treatment: the end of the beginningMichael N Pollak
Cancer Prevention Research (Philadelphia, Pa.)|December 29, 2018
Cancer Prevention: A Message from the New Editors-in-ChiefRaymond N DuBois, Michael N Pollak
Nature Reviews. Cancer|April 3, 2003
Challenges to cancer control by screeningMichael N Pollak, William D Foulkes
Cancer Prevention Research (Philadelphia, Pa.)|November 1, 2022
Introducing Cancer Center Director Perspectives on PreventionRaymond N DuBois, Michael N Pollak
Cancer Prevention Research (Philadelphia, Pa.)|April 1, 2026
Appetite, Obesity, Metabolism, and Malignancy: Do Incretin-Mimetic Drugs Reduce Cancer Risk?Andrew G Renehan, Michael N Pollak
The Journal of Urology|December 3, 2014
The use of aspirin and the risk of mortality in patients with prostate cancerJonathan Assayag, Michael N Pollak, Laurent Azoulay
NPJ Precision Oncology|October 3, 2024
Targeting IGF-IR improves neoadjuvant chemotherapy efficacy in breast cancers with low IGFBP7 expressionChristopher Godina, Michael N Pollak, Helena Jernström
European Journal of Cancer (Oxford, England : 1990)|September 11, 2014
Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancerJonathan Assayag, Michael N Pollak, Laurent Azoulay
Pageof 18